With a focus on decentralization and increased viral load testing, community laboratories are crucial in achieving ambitious federal goals to decrease infections. They offer rapid testing, closer patient care, and the necessary infrastructure to support eradication efforts. Furthermore, these labs play a critical role in continuous monitoring, personalized care, and support for individuals living with HIV and HCV. This shift presents an opportunity to capitalize on investments, innovate, and tackle the challenges posed by these infections. This whitepaper highlights the pivotal role of local laboratories in diagnosing and preventing HIV and HCV infections.
This content is sponsored by: